Fulgent Genetics Inc FLGT

NAS: FLGT | ISIN: US3596641098   30/04/2025
17,35 USD (-4,30%)
(-4,30%)   30/04/2025
Grafiek Fulgent Genetics Inc Grafiek Fulgent Genetics Inc
vrijdag 2 mei 2025, 13:00
Kwartaalcijfers (1ste kwartaal)

Fulgent Genetics Inc in het nieuws

9 februari 2024 · Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing · Persbericht

11 april 2023 · Mission Bio Partners with Fulgent Genetics to Broaden Accessibility of Single-Cell Multi-Omics for Drug Development and Clinical Research · Persbericht

18 november 2022 · Fulgent Genetics, Inc. Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Important Lead Plaintiff Deadline on November 21, 2022 in Securities Fraud Class Action Lawsuit · Persbericht

11 november 2022 · FLGT Investors Have Opportunity to Lead Fulgent Genetics, Inc. Securities Fraud Lawsuit · Persbericht

10 november 2022 · Lead Plaintiff Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed against Fulgent Genetics, Inc. · Persbericht

23 oktober 2022 · FLGT Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Fulgent Genetics, Inc. of Deadline in Securities Fraud Class Action Lawsuit · Persbericht

17 oktober 2022 · FLGT Investors Have Opportunity to Lead Fulgent Genetics, Inc. Securities Fraud Lawsuit · Persbericht

15 oktober 2022 · FULGENT GENETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Fulgent Genetics, Inc. - FLGT · Persbericht

14 oktober 2022 · Attention Shareholders: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Securities Fraud Class Action Lawsuit Filed against Fulgent Genetics, Inc. and Encourages Investors to Contact the Firm · Persbericht

4 oktober 2022 · Kessler Topaz Meltzer & Check, LLP Reminds Fulgent Genetics, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit · Persbericht

Profiel Fulgent Genetics Inc

Gezondheidszorg
Medische/verpleegkundige diensten
Productie
Tandheelkundige laboratoria

Website: www.fulgentgenetics.com

Hoofdzetel: Temple City, California vlag Verenigde Staten

CEO: Ming Hsieh

Werknemers: 428

Mijn selecties